Clinical Trial: A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939829) titled 'A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections' on April 15.

Brief Summary: The objective of this study is to determine whether continuous infusion of ceftazidime-avibactam (CAZ-AVI) could improve clinical outcomes in critically ill patients compared with intermittent infusion.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Patients With Critically Ill Infections

Intervention: DRUG: treatment with CAZ-AVI

Randomize subjects to receive CAZ-AVI via either continuous infusion or intermittent infusion. The total d...